Business & Industry
FDA Issues 3 Priority Vouchers for Psychedelic Drug Firms
The US Food and Drug Administration has awarded three additional Commissioner's National Priority Vouchers under its accelerated regulatory framework, targeting companies developing psychedelic-based therapies. The move follows President Donald Trump’s April 18 executive order aimed at advancing mental health...
Business & Industry
MSD Google Cloud Partnership Drives AI Adoption at Scale
MSD has entered into a multi-year agreement with Google Cloud valued at up to $1 billion, enabling widespread deployment of advanced artificial intelligence tools across its global workforce of 75,000 employees. The collaboration will integrate Google Cloud’s agentic AI...
Business & Industry
AbbVie to Invest $1.4B in North Carolina Manufacturing Plant
AbbVie has outlined plans to build a major new manufacturing facility in Durham, committing $1.4 billion to what will become its largest single-campus capital investment to date. The project, spread across 185 acres, is expected to generate more than...
News
Where to Find Packaging Equipment That Meets Pharmaceutical Standards
In pharmaceutical manufacturing, you operate in an environment where precision, traceability and compliance define every decision you make. That’s why choosing the right FDA-compliant packaging equipment and working with experienced pharmaceutical packaging machinery suppliers is essential from the very...
Health & Wellness
Where to Find Leading Certification Programs for Regulatory Compliance
When you decide to buy regulatory compliance certification online, you’re stepping into a space that demands careful evaluation. You’re making a decision that can directly influence your credibility, career trajectory and long-term earning potential. The stakes are high, and...
BioPharma
Trump Order Targets Faster Psychedelic Drug Reviews by FDA
The Trump administration has introduced a new executive order designed to accelerate Psychedelic Drug Reviews, marking a notable policy move aimed at expediting regulatory pathways for emerging mental health treatments. The directive focuses on advancing FDA evaluation processes for...
Business & Industry
Boehringer Ingelheim Launches New AI R&D Centre in London
Boehringer Ingelheim has introduced a new artificial intelligence (AI) and machine learning (ML) facility in London, strengthening its efforts to integrate advanced technologies into pharmaceutical research. The AI R&D centre will focus on applying AI models to support the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.